Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v8-FR | Version v3-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2023-03-06 | 2023-02-06 |
| Drug Identification Number | 02237514 | 02237514 |
| Brand name | CIPRO ORAL SUSPENSION | CIPRO ORAL SUSPENSION |
| Common or Proper name | Ciprofloxacin Suspension | Ciprofloxacin Suspension |
| Company Name | BAYER INC | BAYER INC |
| Ingredients | CIPROFLOXACIN | CIPROFLOXACIN |
| Strength(s) | 500MG | 500MG |
| Dosage form(s) | SUSPENSION | SUSPENSION |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | 100 mL | 100 mL |
| ATC code | J01MA | J01MA |
| ATC description | QUINOLONE ANTIBACTERIALS | QUINOLONE ANTIBACTERIALS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2023-03-06 | 2023-02-17 |
| Actual start date | ||
| Estimated end date | 2023-03-10 | 2023-02-22 |
| Actual end date | 2023-03-03 | |
| Shortage status | Avoided shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Supply Constraints | Supply Constraints |
| Health Canada comments |